Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -2,264 | N/A | N/A |
| Depreciation Amortization | 230 | N/A | N/A |
| Accounts payable and accrued liabilities | 82 | N/A | N/A |
| Other Working Capital | 409 | N/A | N/A |
| Other Operating Activity | 814 | 0 | 0 |
| Operating Cash Flow | $-729 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -45 | N/A | N/A |
| Purchase Sale Intangibles | -3 | N/A | N/A |
| Other Investing Activity | -3 | 0 | 0 |
| Investing Cash Flow | $-49 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 333 | N/A | N/A |
| Debt Repayment | -177 | N/A | N/A |
| Common Stock Issued | 668 | N/A | N/A |
| Common Stock Repurchased | -28 | N/A | N/A |
| Financing Cash Flow | $796 | $N/A | $N/A |
| End Cash Position | 18 | N/A | N/A |
| Net Cash Flow | $18 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -729 | N/A | N/A |
| Capital Expenditure | -45 | N/A | N/A |
| Free Cash Flow | -775 | 0 | 0 |